Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Verona names Biresh Roy CFO

This article was originally published in Scrip

Executive Summary

Verona Pharma, a drug development company focused on first-in-class medicines to treat respiratory diseases, has appointed Biresh Roy chief financial officer and a member of its board of directors – effective immediately. He takes over from Richard Bungay, whose appointment was part-time and a non-board role. Prior to joining Cardiff, Wales-based Verona Mr Roy founded Ebury Capital and Growth Solutions, a professional services and investment boutique focused on executing change and investing in AIM and privately backed companies.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts